This is a table of type unigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
unigram | frequency |
---|---|
bcg | 2909 |
covid | 1492 |
patients | 1334 |
vaccination | 1269 |
vaccine | 1238 |
cells | 1023 |
infection | 844 |
disease | 827 |
immune | 783 |
countries | 749 |
cell | 659 |
sars | 654 |
study | 646 |
immunity | 636 |
cov | 620 |
also | 585 |
clinical | 564 |
tuberculosis | 559 |
may | 557 |
response | 501 |
cd | 491 |
mortality | 490 |
infections | 486 |
vaccines | 465 |
population | 463 |
years | 458 |
cases | 446 |
data | 441 |
effects | 441 |
virus | 424 |
associated | 419 |
studies | 412 |
treatment | 406 |
human | 393 |
specific | 386 |
responses | 386 |
trained | 382 |
effect | 381 |
high | 378 |
results | 373 |
analysis | 364 |
number | 360 |
leprosy | 357 |
risk | 348 |
protection | 344 |
age | 343 |
non | 340 |
protein | 339 |
respiratory | 332 |
severe | 331 |
il | 331 |
coronavirus | 331 |
induced | 316 |
viral | 312 |
one | 310 |
time | 303 |
two | 303 |
however | 300 |
expression | 295 |
health | 291 |
case | 287 |
different | 283 |
innate | 283 |
used | 282 |
cancer | 279 |
based | 278 |
inflammatory | 278 |
group | 274 |
syndrome | 273 |
mice | 271 |
calmette | 267 |
including | 267 |
reported | 267 |
using | 266 |
preprint | 259 |
low | 256 |
children | 253 |
well | 251 |
significant | 249 |
per | 249 |
mycobacterium | 249 |
role | 246 |
factors | 245 |
found | 245 |
diseases | 245 |
protective | 245 |
first | 244 |
pandemic | 241 |
rate | 240 |
increased | 239 |
macrophages | 238 |
system | 236 |
development | 232 |
due | 230 |
control | 228 |
gene | 225 |
trials | 225 |
antigen | 223 |
policy | 223 |
available | 223 |
review | 222 |
related | 221 |
therapy | 220 |
i | 219 |
use | 219 |
following | 218 |
will | 218 |
new | 215 |
among | 215 |
levels | 213 |
individuals | 213 |
infected | 212 |
several | 211 |
patient | 210 |
production | 207 |
diagnosis | 207 |
evidence | 205 |
influenza | 204 |
hiv | 203 |
shown | 200 |
th | 198 |
universal | 198 |
type | 197 |
higher | 194 |
potential | 192 |
compared | 192 |
table | 191 |
attenuated | 191 |
showed | 187 |
early | 187 |
primary | 185 |
trial | 184 |
country | 183 |
acute | 183 |
license | 183 |
although | 182 |
salmonella | 182 |
tb | 181 |
observed | 181 |
months | 178 |
lower | 177 |
bacillus | 176 |
cytokine | 175 |
immunization | 174 |
impact | 173 |
correlation | 172 |
antigens | 172 |
medrxiv | 171 |
strains | 171 |
doi | 170 |
model | 168 |
million | 168 |
world | 168 |
administration | 167 |
without | 166 |
anti | 165 |
efficacy | 164 |
host | 164 |
recent | 163 |
deaths | 162 |
immunodeficiency | 161 |
novel | 159 |
present | 159 |
antibodies | 159 |
activation | 158 |
test | 158 |
rates | 157 |
association | 156 |
prevention | 155 |
infectious | 155 |
since | 155 |
live | 155 |
current | 154 |
long | 153 |
autoimmune | 153 |
important | 153 |
positive | 152 |
vaccinated | 152 |
like | 150 |
antibody | 150 |
lactoferrin | 149 |
chronic | 149 |
dna | 149 |
less | 148 |
global | 148 |
factor | 148 |
strain | 148 |
coverage | 147 |
pid | 147 |
activity | 145 |
many | 145 |
groups | 145 |
reduced | 144 |
binding | 144 |
memory | 144 |
genetic | 144 |
year | 144 |
possible | 144 |
exposure | 143 |
days | 143 |
three | 143 |
total | 142 |
post | 141 |
cytokines | 141 |
deficiency | 140 |
tests | 140 |
function | 140 |
lf | 139 |
similar | 139 |
known | 138 |
national | 138 |
mkp | 138 |
outcomes | 138 |
morbidity | 138 |
testing | 137 |
incidence | 137 |
pneumonia | 137 |
proteins | 137 |
monocytes | 135 |
dc | 135 |
mediated | 134 |
lps | 134 |
genes | 133 |
symptoms | 133 |
pathogens | 133 |
mycobacterial | 132 |
made | 132 |
care | 132 |
research | 132 |
key | 132 |
international | 132 |
cord | 131 |
level | 131 |
bacterial | 130 |
recombinant | 130 |
effective | 128 |
authors | 128 |
bovis | 128 |
bladder | 127 |
developed | 127 |
mucosal | 125 |
pd | 125 |
addition | 124 |
therefore | 124 |
blf | 124 |
systemic | 124 |
date | 123 |
described | 122 |
report | 122 |
significantly | 121 |
considered | 120 |
vitro | 120 |
tnf | 119 |
spread | 119 |
even | 119 |
given | 119 |
induction | 119 |
randomized | 118 |
igg | 117 |
death | 117 |
oral | 117 |
blood | 117 |
version | 116 |
humans | 116 |
copyright | 116 |
severity | 115 |
changes | 115 |
mutation | 114 |
policies | 114 |
medical | 114 |
findings | 114 |
major | 114 |
display | 114 |
lung | 114 |
author | 113 |
another | 113 |
demonstrated | 113 |
large | 112 |
via | 111 |
immunological | 111 |
common | 111 |
performed | 111 |
china | 110 |
controlled | 110 |
statistical | 109 |
normal | 109 |
receptor | 109 |
increase | 109 |
caused | 108 |
within | 108 |
old | 108 |
diagnosed | 108 |
experimental | 108 |
included | 107 |
identified | 107 |
epidemiological | 107 |
prevalence | 106 |
bacille | 106 |
strong | 106 |
multiple | 105 |
differences | 105 |
phase | 104 |
dose | 104 |
inflammation | 104 |
mechanisms | 104 |
mutations | 103 |
might | 103 |
day | 103 |
small | 103 |
africa | 103 |
lymph | 103 |
people | 103 |
granted | 102 |
birth | 102 |
guerin | 102 |
treated | 102 |
safety | 102 |
need | 102 |
induce | 101 |
survival | 101 |
therapeutic | 100 |
life | 100 |
healthy | 100 |
single | 99 |
holder | 99 |
recurrent | 99 |
income | 99 |
immunogenicity | 99 |
cvid | 99 |
funder | 99 |
ifn | 98 |
contacts | 98 |
hospital | 98 |
term | 97 |
bacteria | 97 |
perpetuity | 97 |
provide | 97 |
vivo | 97 |
likely | 97 |
negative | 96 |
history | 96 |
sign | 96 |
populations | 96 |
regression | 95 |
induces | 95 |
challenge | 95 |
outcome | 94 |
posted | 94 |
models | 94 |
pcr | 93 |
dependent | 93 |
enhanced | 93 |
complications | 92 |
various | 92 |
molecular | 91 |
tlr | 91 |
drugs | 91 |
epigenetic | 91 |
received | 90 |
confirmed | 90 |
mechanism | 90 |
measles | 90 |
heterologous | 90 |
according | 90 |
four | 90 |
program | 90 |
ml | 89 |
whether | 89 |
mg | 89 |
stimulation | 89 |
adults | 88 |
drug | 88 |
currently | 88 |
approach | 88 |
adverse | 87 |
site | 87 |
follow | 87 |
variable | 87 |
period | 87 |
delivery | 87 |
recently | 86 |
laboratory | 86 |
revealed | 86 |
result | 86 |
family | 86 |
tract | 86 |
reports | 86 |
presence | 86 |
protect | 85 |
middle | 85 |
https | 85 |
previous | 85 |
adjuvant | 84 |
presented | 84 |
infants | 84 |
previously | 84 |
tissue | 84 |
highly | 83 |
elderly | 83 |
transmission | 83 |
mm | 83 |
status | 82 |
show | 81 |
reduction | 81 |
expressing | 81 |
growth | 81 |
pathway | 81 |
fever | 81 |
chemoprophylaxis | 81 |
expressed | 80 |
conditions | 80 |
pathways | 80 |
natural | 80 |
hypothesis | 80 |
respectively | 80 |
sdr | 80 |
combined | 80 |
virulence | 80 |
viruses | 79 |
org | 79 |
methods | 79 |
stat | 79 |
phop | 79 |
required | 79 |
cause | 79 |
co | 79 |
suggest | 79 |
dendritic | 78 |
skin | 78 |
cc | 78 |
cross | 78 |
capacity | 78 |
cohort | 77 |
additional | 77 |
regulation | 77 |
regarding | 77 |
derived | 77 |
pep | 77 |
decreased | 77 |
india | 76 |
april | 76 |
defined | 76 |
limited | 76 |
value | 76 |
administered | 75 |
work | 75 |
difference | 74 |
either | 74 |
diagnostic | 74 |
local | 74 |
acid | 73 |
variables | 73 |
characteristics | 73 |
obtained | 73 |
nodes | 72 |
median | 72 |
characterized | 72 |
nd | 72 |
university | 72 |
include | 72 |
journal | 72 |
prevent | 72 |
scid | 72 |
activated | 72 |
onset | 71 |
vector | 71 |
second | 71 |
adaptive | 71 |
rapid | 70 |
method | 70 |
still | 70 |
published | 70 |
seen | 69 |
measures | 69 |
tumor | 69 |
information | 69 |
literature | 69 |
detected | 69 |
upper | 69 |
tested | 69 |
id | 69 |
despite | 69 |
suggested | 69 |
least | 69 |
initial | 68 |
rna | 68 |
pathogen | 68 |
surface | 68 |
intravesical | 68 |
active | 68 |
ivig | 67 |
ii | 67 |
needed | 67 |
igm | 67 |
critical | 67 |
antiviral | 67 |
reduce | 67 |
hepatitis | 66 |
systematic | 66 |
action | 66 |
essential | 66 |
pro | 66 |
receptors | 66 |
example | 66 |
cellular | 66 |
support | 66 |
pulmonary | 66 |
delayed | 66 |
disorders | 65 |
lack | 65 |
nk | 65 |
adjuvants | 65 |
born | 65 |
immunotherapy | 65 |
just | 65 |
susceptibility | 64 |
better | 64 |
beneficial | 64 |
membrane | 64 |
mycobacteria | 64 |
past | 63 |
followed | 63 |
standard | 63 |
expected | 63 |
contact | 63 |
form | 63 |
young | 63 |
analyses | 62 |
region | 62 |
rd | 62 |
lymphocytes | 62 |
future | 62 |
screening | 62 |
coli | 62 |
weeks | 62 |
title | 62 |
phenotype | 61 |
affected | 61 |
management | 61 |
peer | 61 |
moreover | 61 |
sha | 61 |
center | 61 |
doc | 61 |
uid | 61 |
parameters | 61 |
systems | 61 |
resulting | 61 |
last | 61 |
effectiveness | 60 |
leprae | 60 |
influence | 60 |
older | 60 |
organization | 60 |
childhood | 60 |
mean | 60 |
evaluation | 60 |
south | 60 |
hsct | 60 |
sequence | 59 |
conclusion | 59 |
distribution | 59 |
target | 59 |
general | 59 |
progression | 59 |
involved | 59 |
significance | 59 |
hla | 59 |
point | 58 |
containing | 58 |
indicated | 58 |
delay | 58 |
index | 58 |
features | 58 |
murine | 58 |
spike | 58 |
mtb | 58 |
worldwide | 58 |
inhabitants | 58 |
combination | 58 |
numbers | 58 |
leads | 58 |
determine | 57 |
serum | 57 |
around | 57 |
social | 57 |
comparison | 57 |
prophylaxis | 57 |
lead | 57 |
complex | 57 |
resistance | 57 |
interaction | 57 |
design | 57 |
iron | 57 |
though | 57 |
fact | 57 |
subjects | 57 |
immunoglobulin | 57 |
guinea | 57 |
regulatory | 57 |
examination | 56 |
detection | 56 |
stage | 56 |
metabolic | 56 |
events | 56 |
adult | 56 |
programs | 56 |
set | 56 |
able | 55 |
ratio | 55 |
nonspecific | 55 |
five | 55 |
nature | 55 |
secretion | 55 |
process | 55 |
analyzed | 55 |
mapk | 55 |
values | 55 |
protects | 55 |
complete | 55 |
whole | 55 |
rare | 55 |
carcinoma | 55 |
neonatal | 55 |
relationship | 54 |
volunteers | 54 |
ability | 54 |
dpm | 54 |
neutralizing | 54 |
guidelines | 54 |
meta | 54 |
epidemic | 54 |
outbreak | 54 |
macrophage | 54 |
candidate | 54 |
range | 54 |
states | 53 |
iga | 53 |
properties | 53 |
lymphocyte | 53 |
transplantation | 53 |
us | 53 |
mass | 53 |
linked | 53 |
pre | 53 |
fatality | 53 |
provided | 53 |
pathogenic | 53 |
leading | 53 |
european | 53 |
sweden | 53 |
resulted | 52 |
database | 52 |
liver | 52 |
replication | 52 |
invasive | 52 |
uk | 52 |
cervical | 51 |
already | 51 |
improved | 51 |
order | 51 |
defects | 51 |
affect | 51 |
cgd | 51 |
taken | 51 |
especially | 51 |
vectors | 51 |
mainly | 51 |
presentation | 51 |
estimated | 51 |
inhibition | 51 |
overall | 51 |
functional | 50 |
immunology | 50 |
arthritis | 50 |
part | 50 |
shows | 50 |
vs | 50 |
developing | 50 |
column | 50 |
signaling | 50 |
far | 50 |
stopped | 50 |
times | 50 |
nc | 50 |
glucan | 50 |
produced | 50 |
evaluated | 50 |
now | 49 |
autoimmunity | 49 |
conducted | 49 |
hlf | 49 |
targeted | 49 |
aged | 49 |
consistent | 49 |
malaria | 49 |
intracellular | 49 |
certified | 49 |
duration | 49 |
typhimurium | 49 |
develop | 49 |
training | 49 |
prior | 49 |
ongoing | 49 |
mild | 49 |
public | 49 |
www | 49 |
linear | 48 |
humoral | 48 |
intervention | 48 |
usa | 48 |
help | 48 |
rifampicin | 48 |
causes | 48 |
types | 48 |
genome | 48 |
relative | 48 |
applied | 48 |
intestinal | 48 |
adherent | 48 |
diabetes | 48 |
workers | 48 |
listeria | 48 |
yet | 48 |
delays | 48 |
additionally | 48 |
vaccinations | 48 |
disseminated | 48 |
interest | 48 |
observations | 48 |
remains | 48 |
furthermore | 48 |
associations | 47 |
later | 47 |
adjusted | 47 |
reducing | 47 |
confidence | 47 |
regional | 47 |
potentially | 47 |
six | 47 |
heat | 47 |
department | 47 |
proportion | 47 |
structure | 47 |
best | 47 |
st | 47 |
protected | 47 |
burden | 47 |
state | 47 |
nct | 47 |
network | 47 |
bone | 47 |
across | 46 |
identify | 46 |
whereas | 46 |
importance | 46 |
must | 46 |
established | 46 |
necessary | 46 |
course | 46 |
independent | 46 |
strategies | 46 |
secondary | 46 |
side | 46 |
indian | 46 |
pediatric | 46 |
produce | 46 |
epithelial | 46 |
subsequent | 46 |
knowledge | 46 |
italy | 46 |
environmental | 46 |
much | 45 |
often | 45 |
account | 45 |
east | 45 |
iii | 45 |
selected | 45 |
safe | 45 |
agents | 45 |
surgery | 45 |
finally | 45 |
mers | 45 |
decrease | 45 |
main | 44 |
ci | 44 |
isolated | 44 |
interestingly | 44 |
stimulated | 44 |
size | 44 |
marrow | 44 |
article | 44 |
occur | 44 |
bcgosis | 44 |
proposed | 44 |
reporting | 44 |
damage | 44 |
particularly | 44 |
coronaviruses | 44 |
reactions | 44 |
united | 44 |
aluminum | 44 |
animal | 43 |
recommended | 43 |
percentage | 43 |
statistically | 43 |
interactions | 43 |
unknown | 43 |
suggesting | 43 |
component | 43 |
determined | 43 |
average | 43 |
sites | 43 |
started | 43 |
correlated | 43 |
versus | 43 |
node | 43 |
epidemics | 43 |
transplant | 43 |
direct | 43 |
physical | 43 |
transcription | 42 |
bovine | 42 |
deletion | 42 |
inhibitor | 42 |
chemotherapy | 42 |
presenting | 42 |
wide | 42 |
prophylactic | 42 |
synthesis | 42 |
studied | 42 |
animals | 42 |
criteria | 41 |
estimates | 41 |
muscle | 41 |
monocytogenes | 41 |
finding | 41 |
renal | 41 |
week | 41 |
frequent | 41 |
highest | 41 |
genomic | 41 |
phosphorylation | 41 |
ace | 41 |
improve | 41 |
mouse | 41 |
regulated | 41 |
contribute | 41 |
generally | 41 |
milk | 41 |
absence | 41 |
late | 41 |
asymptomatic | 41 |
emerging | 40 |
assays | 40 |
retrospective | 40 |
short | 40 |
germany | 40 |
peripheral | 40 |
cfr | 40 |
enterica | 40 |
candidates | 40 |
broad | 40 |
neutrophils | 40 |
usually | 40 |
context | 40 |
hospitalized | 40 |
cost | 40 |
robust | 40 |
components | 40 |
release | 40 |
pathogenesis | 40 |
killed | 40 |
class | 40 |
june | 40 |
loss | 40 |
hand | 40 |
strategy | 40 |
prostate | 40 |
enhance | 39 |
offer | 39 |
sepsis | 39 |
individual | 39 |
approximately | 39 |
functions | 39 |
rv | 39 |
access | 39 |
vasculitis | 39 |
kinase | 39 |
see | 39 |
mo | 39 |
controls | 39 |
wuhan | 39 |
unrelated | 39 |
earlier | 39 |
serious | 39 |
plasma | 39 |
aids | 39 |
certain | 39 |
change | 39 |
greater | 39 |
immunisation | 38 |
healthcare | 38 |
investigated | 38 |
exposed | 38 |
project | 38 |
recovered | 38 |
suggests | 38 |
inoculation | 38 |
routine | 38 |
particular | 38 |
march | 38 |
responsible | 38 |
formation | 38 |
boost | 38 |
child | 38 |
mrna | 38 |
increasing | 38 |
metastatic | 38 |
reactivation | 38 |
delivered | 38 |
reaction | 38 |
ige | 38 |
intravenous | 38 |
approaches | 38 |
lasting | 38 |
strongly | 37 |
attributed | 37 |
doses | 37 |
led | 37 |
molecule | 37 |
preventing | 37 |
weight | 37 |
load | 37 |
antimicrobial | 37 |
pneumococcal | 37 |
quality | 37 |
stem | 37 |
domain | 37 |
histone | 37 |
concentration | 37 |
similarly | 37 |
dl | 37 |
symptomatic | 37 |
microbes | 37 |
relevant | 37 |
fraction | 37 |
appropriate | 37 |
economic | 37 |
cycle | 37 |
rather | 37 |
subunit | 37 |
successful | 37 |
assessed | 37 |
others | 37 |
deficient | 37 |
targeting | 37 |
indicating | 37 |
considering | 36 |
condition | 36 |
causing | 36 |
japan | 36 |
specifically | 36 |
line | 36 |
glycolysis | 36 |
probably | 36 |
alveolar | 36 |
regions | 36 |
treatments | 36 |
immunodeficiencies | 36 |
suppression | 36 |
conclusions | 36 |
way | 36 |
enzymes | 36 |
experience | 36 |
sequencing | 36 |
lm | 36 |
full | 36 |
antibiotic | 36 |
forms | 36 |
cultures | 36 |
brazil | 36 |
increases | 36 |
transcriptional | 36 |
together | 36 |
relatively | 36 |
sirna | 35 |
rapidly | 35 |
background | 35 |
evaluate | 35 |
terms | 35 |
interferon | 35 |
molecules | 35 |
free | 35 |
dr | 35 |
pylori | 35 |
third | 35 |
cohorts | 35 |
implications | 35 |
biopsy | 35 |
scientific | 35 |
lethal | 35 |
paper | 35 |
tetanus | 35 |
advanced | 35 |
challenges | 35 |
pids | 35 |
peptide | 35 |
right | 35 |
practice | 35 |
month | 35 |
called | 35 |
assess | 35 |
done | 35 |
injection | 35 |
flow | 35 |
identification | 35 |
parvum | 35 |
elevated | 35 |
asia | 35 |
measured | 35 |
toll | 35 |
never | 34 |
serovar | 34 |
deficiencies | 34 |
activities | 34 |
provides | 34 |
density | 34 |
introduction | 34 |
central | 34 |
reactive | 34 |
receiving | 34 |
resources | 34 |
contrast | 34 |
signal | 34 |
surveillance | 34 |
practices | 34 |
reprogramming | 34 |
stages | 34 |
benefit | 34 |
grade | 34 |
african | 34 |
observation | 34 |
enhances | 34 |
means | 34 |
indeed | 34 |
discontinuity | 34 |
seems | 33 |
intradermal | 33 |
recovery | 33 |
hpv | 33 |
isolation | 33 |
promising | 33 |
longer | 33 |
experiments | 33 |
potent | 33 |
alone | 33 |
fc | 33 |
therapies | 33 |
mostly | 33 |
every | 33 |
directly | 33 |
imm | 33 |
thought | 33 |
pathology | 33 |
interval | 33 |
areas | 33 |
self | 33 |
hydroxychloroquine | 33 |
basis | 33 |
manifestations | 33 |
fusion | 33 |
died | 32 |
fully | 32 |
defense | 32 |
manuscript | 32 |
household | 32 |
allergy | 32 |
sample | 32 |
circulating | 32 |
entry | 32 |
cessation | 32 |
glycoprotein | 32 |
dcs | 32 |
lesions | 32 |
epidemiology | 32 |
threshold | 32 |
granulomatous | 32 |
ligand | 32 |
randomised | 32 |
com | 32 |
placebo | 32 |
kd | 32 |
importantly | 32 |
institute | 32 |
replacement | 32 |
concentrations | 31 |
elicited | 31 |
divided | 31 |
unique | 31 |
tmprss | 31 |
next | 31 |
protease | 31 |
question | 31 |
recognized | 31 |
antibiotics | 31 |
differential | 31 |
food | 31 |
seven | 31 |
macaques | 31 |
aim | 31 |
appears | 31 |
suppressor | 31 |
enhancement | 31 |
inducing | 31 |
points | 31 |
phor | 31 |
majority | 31 |
admission | 31 |
gaussian | 31 |
variation | 31 |
failure | 31 |
plasmid | 31 |
link | 31 |
scale | 31 |
centre | 31 |
recognition | 31 |
generated | 31 |
approved | 31 |
alignment | 30 |
along | 30 |
urothelial | 30 |
generation | 30 |
resistant | 30 |
patterns | 30 |
prolonged | 30 |
hypothesized | 30 |
showing | 30 |
confounding | 30 |
producing | 30 |
represent | 30 |
daily | 30 |
contains | 30 |
evolution | 30 |
includes | 30 |
efforts | 30 |
distinct | 30 |
instead | 30 |
processes | 30 |
lungs | 30 |
towards | 30 |
samples | 30 |
newborns | 30 |
ecological | 30 |
subcutaneous | 30 |
affecting | 30 |
explain | 30 |
proliferation | 30 |
hospitalizations | 30 |
unvaccinated | 30 |
prospective | 30 |
play | 30 |
russia | 29 |
existing | 29 |
gut | 29 |
illness | 29 |
improvement | 29 |
peptides | 29 |
mammalian | 29 |
alternative | 29 |
open | 29 |
regulate | 29 |
male | 29 |
moderate | 29 |
tumors | 29 |
gastrointestinal | 29 |
admitted | 29 |
helicobacter | 29 |
understanding | 29 |
brain | 29 |
implementation | 29 |
close | 29 |
referred | 29 |
gov | 29 |
require | 29 |
stimulate | 29 |
erk | 28 |
resolution | 28 |
log | 28 |
whose | 28 |
progress | 28 |
good | 28 |
become | 28 |
detailed | 28 |
repeated | 28 |
reviewed | 28 |
disorder | 28 |
comparing | 28 |
signs | 28 |
count | 28 |
body | 28 |
clear | 28 |
effector | 28 |
possibly | 28 |
immunomodulatory | 28 |
route | 28 |
indicators | 28 |
pattern | 28 |
characterization | 28 |
wall | 28 |
concluded | 28 |
lprg | 28 |
clinic | 28 |
hbv | 28 |
comorbidities | 28 |
discussed | 28 |
polymorphisms | 28 |
widely | 28 |
persistent | 28 |
proven | 28 |
pt | 28 |
area | 28 |
concerns | 28 |
buffer | 28 |
yellow | 28 |
mutants | 28 |
escherichia | 28 |
risks | 28 |
lopinavir | 28 |
targets | 28 |
iv | 28 |
recurrence | 28 |
frequently | 28 |
clinically | 28 |
gamma | 27 |
predicted | 27 |
hypogammaglobulinemia | 27 |
situation | 27 |
mutant | 27 |
raised | 27 |
blockade | 27 |
concern | 27 |
modifications | 27 |
incubated | 27 |
pasteur | 27 |
mhc | 27 |
phagocytic | 27 |
enriched | 27 |
commonly | 27 |
deletions | 27 |
spectrum | 27 |
convalescent | 27 |
bind | 27 |
besides | 27 |
enzyme | 27 |
modified | 27 |
adjustment | 27 |
directed | 27 |
variety | 27 |
frequency | 27 |
injected | 27 |
treat | 27 |
pigs | 27 |
granuloma | 27 |
typically | 27 |
take | 27 |
comparative | 27 |
hematopoietic | 27 |
designed | 27 |
capita | 27 |
search | 27 |
express | 27 |
supported | 27 |
nod | 27 |
poor | 27 |
signr | 27 |
regard | 27 |
allergic | 27 |
hours | 26 |
biological | 26 |
impaired | 26 |
asthma | 26 |
culture | 26 |
parents | 26 |
western | 26 |
field | 26 |
smoking | 26 |
immunocompromised | 26 |
setting | 26 |
radiotherapy | 26 |
platform | 26 |
heart | 26 |
pca | 26 |
reduces | 26 |
interleukin | 26 |
possibility | 26 |
epitopes | 26 |
left | 26 |
ag | 26 |
preliminary | 26 |
manufacturing | 26 |
allows | 26 |
settings | 26 |
suspected | 26 |
reserved | 26 |
metabolism | 26 |
emergency | 26 |
killer | 26 |
atlas | 26 |
clinicaltrials | 26 |
intermediate | 26 |
dental | 26 |
make | 26 |
degree | 26 |
ph | 26 |
availability | 26 |
underlying | 26 |
nan | 26 |
documented | 26 |
assay | 26 |
throughout | 25 |
compounds | 25 |
requires | 25 |
intensive | 25 |
confounders | 25 |
living | 25 |
demographic | 25 |
herpes | 25 |
publication | 25 |
rights | 25 |
elicit | 25 |
pharmacological | 25 |
making | 25 |
ligands | 25 |
investigate | 25 |
cytometry | 25 |
radical | 25 |
ct | 25 |
cpn | 25 |
encoding | 25 |
calculated | 25 |
syncytial | 25 |
subsequently | 25 |
numerous | 25 |
yr | 25 |
microbial | 25 |
plays | 25 |
dusp | 25 |
female | 25 |
inactivated | 25 |
participants | 25 |
indicate | 25 |
ppd | 25 |
environment | 25 |
place | 25 |
kg | 25 |
profile | 25 |
stable | 25 |
lymphopenia | 25 |
du | 25 |
almost | 25 |
larger | 25 |
confer | 25 |
silicone | 25 |
preventive | 25 |
failed | 25 |
chloroquine | 25 |
tolerance | 25 |
latter | 25 |
shock | 24 |
assessing | 24 |
causal | 24 |
intervals | 24 |
hyper | 24 |
washed | 24 |
medicine | 24 |
rt | 24 |
timing | 24 |
autoantibodies | 24 |
needs | 24 |
benefits | 24 |
providing | 24 |
boy | 24 |
supporting | 24 |
stop | 24 |
medium | 24 |
origin | 24 |
mva | 24 |
markers | 24 |
differentiation | 24 |
species | 24 |
start | 24 |
lipopolysaccharide | 24 |
endemic | 24 |
options | 24 |
temperature | 24 |
europe | 24 |
rho | 24 |
useful | 24 |
science | 24 |
promoter | 24 |
cholesterol | 24 |
selective | 24 |
introduced | 24 |
chain | 24 |
attributable | 24 |
application | 24 |
boosting | 24 |
heterogeneous | 24 |
maintenance | 24 |
summary | 24 |
except | 24 |
interventions | 24 |
registry | 24 |
kda | 24 |
remain | 23 |
variability | 23 |
screened | 23 |
clearance | 23 |
hypersensitivity | 23 |
acquired | 23 |
exhibit | 23 |
collected | 23 |
prime | 23 |
investigation | 23 |
kawasaki | 23 |
candida | 23 |
typhi | 23 |
granulomas | 23 |
ad | 23 |
community | 23 |
estimate | 23 |
oxygen | 23 |
infant | 23 |
survey | 23 |
donor | 23 |
feature | 23 |
noted | 23 |
confirm | 23 |
crucial | 23 |
unlikely | 23 |
members | 23 |
manifestation | 23 |
foreign | 23 |
restricted | 23 |
focus | 23 |
recommendations | 23 |
defect | 23 |
counts | 23 |
lupus | 23 |
none | 23 |
phosphate | 23 |
prrs | 23 |
consensus | 22 |
monocyte | 22 |
scar | 22 |
reconstitution | 22 |
half | 22 |
rise | 22 |
agent | 22 |
shigella | 22 |
unit | 22 |
kidney | 22 |
monitoring | 22 |
guide | 22 |
dock | 22 |
tca | 22 |
breast | 22 |
starting | 22 |
australia | 22 |
selection | 22 |
requiring | 22 |
examined | 22 |
genetically | 22 |
biosynthesis | 22 |
find | 22 |
colleagues | 22 |
stm | 22 |
map | 22 |
top | 22 |
min | 22 |
consequences | 22 |
tice | 22 |
dynamics | 22 |
rcts | 22 |
inhibitors | 22 |
carried | 22 |
mother | 22 |
share | 22 |
original | 22 |
differ | 22 |
necrosis | 22 |
end | 22 |
consider | 22 |
infancy | 22 |
amino | 22 |
gp | 22 |
promoters | 22 |
ex | 22 |
complicated | 21 |
occurred | 21 |
bias | 21 |
limitations | 21 |
birkhaug | 21 |
draining | 21 |
susceptible | 21 |
albicans | 21 |
reflect | 21 |
controlling | 21 |
resection | 21 |
candidiasis | 21 |
light | 21 |
mentioned | 21 |
fatty | 21 |
education | 21 |
netherlands | 21 |
proinflammatory | 21 |
immunized | 21 |
ighy | 21 |
hospitalization | 21 |
multi | 21 |
myeloid | 21 |
seasonal | 21 |
threatening | 21 |
labv | 21 |
nevertheless | 21 |
infusion | 21 |
autosomal | 21 |
organ | 21 |
inhibits | 21 |
diversity | 21 |
contain | 21 |
red | 21 |
apcs | 21 |
explained | 21 |
marker | 21 |
coefficient | 21 |
rubella | 21 |
initiated | 21 |
view | 21 |
act | 21 |
details | 21 |
toxicity | 21 |
initiation | 21 |
statistics | 21 |
page | 21 |
supplementary | 21 |
validated | 21 |
attenuation | 21 |
bp | 21 |
women | 21 |
lysate | 21 |
immunopathology | 21 |
observational | 21 |
fatal | 21 |
latent | 21 |
generate | 21 |
modulatory | 21 |
inhibit | 21 |
surgical | 21 |
annual | 21 |
reasons | 20 |
july | 20 |
defective | 20 |
spleen | 20 |
ubip | 20 |
seem | 20 |
sds | 20 |
decades | 20 |
invasion | 20 |
cytotoxic | 20 |
achieved | 20 |
pamps | 20 |
deliver | 20 |
source | 20 |
stimuli | 20 |
error | 20 |
modulation | 20 |
suitable | 20 |
bissau | 20 |
toward | 20 |
exponential | 20 |
facilitate | 20 |
ig | 20 |
beyond | 20 |
demonstrate | 20 |
abnormal | 20 |
affinity | 20 |
promote | 20 |
added | 20 |
prevents | 20 |
dataset | 20 |
west | 20 |
girl | 20 |
position | 20 |
infect | 20 |
localized | 20 |
effectively | 20 |
ade | 20 |
underwent | 20 |
complement | 20 |
sufficient | 20 |
cgs | 20 |
indicates | 20 |
amount | 20 |
accordingly | 20 |
limit | 20 |
efficient | 20 |
generalized | 20 |
implemented | 20 |
great | 20 |
problem | 20 |
involvement | 20 |
fewer | 20 |
etc | 20 |
esx | 20 |
viable | 20 |
outbreaks | 20 |
escape | 20 |
sp | 20 |
dnak | 20 |
costs | 20 |
experiment | 20 |
expert | 20 |
immunosuppressive | 20 |
priming | 20 |
exhibits | 20 |
recorded | 20 |
phox | 20 |
spain | 20 |
assessment | 20 |
nationwide | 20 |
globally | 19 |
tissues | 19 |
classical | 19 |
lipoprotein | 19 |
auto | 19 |
classification | 19 |
problems | 19 |
inclusion | 19 |
mandatory | 19 |
rc | 19 |
syndromes | 19 |
biochemical | 19 |
atherosclerosis | 19 |
van | 19 |
wild | 19 |
families | 19 |
ra | 19 |
respect | 19 |
optimal | 19 |
aldrich | 19 |
thank | 19 |
diarrhea | 19 |
remdesivir | 19 |
mononuclear | 19 |
concept | 19 |
cancers | 19 |
conflict | 19 |
considerable | 19 |
rarely | 19 |
questions | 19 |
estimator | 19 |
infrastructure | 19 |
remained | 19 |
virulent | 19 |
ar | 19 |
reinfection | 19 |
typical | 19 |
superficial | 19 |
namely | 19 |
baseline | 19 |
trend | 19 |
allowed | 19 |
france | 19 |
estimation | 19 |
articles | 19 |
appear | 19 |
know | 19 |
recessive | 19 |
contributed | 19 |
issues | 19 |
serological | 19 |
distancing | 19 |
cumulative | 19 |
protocol | 19 |
relation | 19 |
structural | 19 |
melanoma | 19 |
helper | 19 |
multivariable | 19 |
measure | 19 |
reference | 19 |
etiology | 19 |
chinese | 19 |
msmd | 19 |
protocols | 19 |
marked | 19 |
deviation | 19 |
protecting | 19 |
substantial | 19 |
score | 19 |
superior | 19 |
discovery | 19 |
reliable | 19 |
sequences | 19 |
activating | 19 |
double | 19 |
school | 19 |
cardiovascular | 19 |
turkey | 19 |
plot | 19 |
antiretroviral | 19 |
extent | 19 |
american | 19 |
aerosol | 19 |
trigger | 18 |
products | 18 |
abscess | 18 |
rotavirus | 18 |
immediate | 18 |
altered | 18 |
os | 18 |
mdp | 18 |
mixed | 18 |
rheumatoid | 18 |
web | 18 |
curve | 18 |
units | 18 |
extracted | 18 |
face | 18 |
section | 18 |
sc | 18 |
colep | 18 |
variations | 18 |
facilities | 18 |
plus | 18 |
nucleocapsid | 18 |
adequate | 18 |
serve | 18 |
depends | 18 |
biology | 18 |
rhesus | 18 |
caution | 18 |
matched | 18 |
avoid | 18 |
comprising | 18 |
fold | 18 |
vaccinia | 18 |
correlations | 18 |
magnitude | 18 |
gram | 18 |
overview | 18 |
infiltration | 18 |
get | 18 |
online | 18 |
fractions | 18 |
appeared | 18 |
propose | 18 |
elicits | 18 |
enhancing | 18 |
represents | 18 |
revaccination | 18 |
representing | 18 |
beta | 18 |
toxin | 18 |
meningitis | 18 |
product | 18 |
moreau | 18 |
expansion | 18 |
hence | 18 |
clearly | 18 |
true | 18 |
occurs | 18 |
swedish | 18 |
cm | 18 |
frequencies | 18 |
maximum | 18 |
homozygous | 18 |
continued | 18 |
displayed | 18 |
extensive | 18 |
endotoxemia | 18 |
completely | 18 |
century | 18 |
jnk | 18 |
persistence | 17 |
sensitivity | 17 |
explored | 17 |
pneumoniae | 17 |
presents | 17 |
moment | 17 |
perform | 17 |
shift | 17 |
antimycobacterial | 17 |
incomplete | 17 |
material | 17 |
mapks | 17 |
preclinical | 17 |
aimed | 17 |
morbidities | 17 |
newborn | 17 |
precision | 17 |
expectancy | 17 |
resource | 17 |
aureus | 17 |
establishment | 17 |
binds | 17 |
mimics | 17 |
sub | 17 |
malignancies | 17 |
probability | 17 |
spp | 17 |
upregulation | 17 |
loads | 17 |
cultured | 17 |
chest | 17 |
streptococcus | 17 |
step | 17 |
initially | 17 |
iran | 17 |
permission | 17 |
xla | 17 |
city | 17 |
cpm | 17 |
achieve | 17 |
plasmids | 17 |
mtor | 17 |
wk | 17 |
cmap | 17 |
regimens | 17 |
discovered | 17 |
aeruginosa | 17 |
little | 17 |
itaconate | 17 |
zero | 17 |
reveals | 17 |
diverse | 17 |
understood | 17 |
unlike | 17 |
mmr | 17 |
congenital | 17 |
continuous | 17 |
corona | 17 |
stated | 17 |
random | 17 |
weak | 17 |
probable | 17 |
publicly | 17 |
lipid | 17 |
lactis | 17 |
colonization | 17 |
stress | 17 |
phenotypes | 17 |
immunol | 17 |
itp | 17 |
technology | 17 |
covariates | 17 |
accumulation | 17 |
injury | 17 |
allow | 17 |
capable | 17 |
addressed | 17 |
reason | 17 |
erythematosus | 17 |
ncov | 17 |
committee | 17 |
prevented | 17 |
storm | 17 |
always | 17 |
subsets | 17 |
prevalent | 17 |
envelope | 17 |
repurposing | 17 |
glucose | 17 |
beginning | 16 |
lockdown | 16 |
focused | 16 |
indians | 16 |
reactivity | 16 |
inhibiting | 16 |
leukocyte | 16 |
progressive | 16 |
neonates | 16 |
proved | 16 |
dehydrogenase | 16 |
glycolytic | 16 |
corresponding | 16 |
fungal | 16 |
comparable | 16 |
closely | 16 |
predict | 16 |
subtilis | 16 |
cough | 16 |
slightly | 16 |
androgen | 16 |
nacl | 16 |
wave | 16 |
adenovirus | 16 |
residents | 16 |
implementing | 16 |
sigma | 16 |
option | 16 |
oxphos | 16 |
contribution | 16 |
conventional | 16 |
difficult | 16 |
ms | 16 |
distress | 16 |
ltbi | 16 |
sex | 16 |
phosphatase | 16 |
excluded | 16 |
supply | 16 |
switched | 16 |
urgent | 16 |
content | 16 |
ln | 16 |
issue | 16 |
neoadjuvant | 16 |
mediators | 16 |
microorganisms | 16 |
series | 16 |
software | 16 |
modulate | 16 |
pbmcs | 16 |
underway | 16 |
regimen | 16 |
working | 16 |
advantage | 16 |
agonists | 16 |
reviews | 16 |
front | 16 |
fit | 16 |
organisms | 16 |
varying | 16 |
flexneri | 16 |
thrombocytopenia | 16 |
reached | 16 |
believed | 16 |
regular | 16 |
noteworthy | 16 |
therapeutics | 16 |
partially | 16 |
sibling | 16 |
causality | 16 |
carrying | 16 |
nf | 16 |
pertussis | 16 |
procedures | 16 |
cvd | 16 |
spm | 16 |
adjuvanted | 16 |
ac | 16 |
lpep | 16 |
dissemination | 16 |
determining | 16 |
balb | 16 |
nitric | 16 |
immunosuppression | 16 |
tool | 16 |
wheezing | 16 |
construction | 16 |
rationale | 16 |
real | 16 |
tuberculin | 16 |
notably | 16 |
oncology | 16 |
feasible | 16 |
transfer | 16 |
eluted | 16 |
termed | 16 |
funding | 16 |
ic | 16 |
robustness | 15 |
urine | 15 |
demographics | 15 |
scig | 15 |
siv | 15 |
enrichment | 15 |
give | 15 |
establish | 15 |
reach | 15 |
declare | 15 |
explanation | 15 |
ref | 15 |
intestine | 15 |
denmark | 15 |
immunoglobulins | 15 |
occurrence | 15 |
normally | 15 |
regressions | 15 |
gapdh | 15 |
reverse | 15 |
compound | 15 |
array | 15 |
kong | 15 |
persist | 15 |
involving | 15 |
reproduction | 15 |
downstream | 15 |
dominant | 15 |
recommend | 15 |
records | 15 |
ataxia | 15 |
malignancy | 15 |
nsp | 15 |
lesion | 15 |
scatter | 15 |
prepared | 15 |
pain | 15 |
consideration | 15 |
success | 15 |
hcov | 15 |
bacilli | 15 |
absent | 15 |
amounts | 15 |
encodes | 15 |
cluster | 15 |
run | 15 |
september | 15 |
partial | 15 |
maintained | 15 |
signature | 15 |
reasoning | 15 |
knockout | 15 |
toxoid | 15 |
genetics | 15 |
computed | 15 |
urinary | 15 |
otherwise | 15 |
hies | 15 |
neutrophil | 15 |
infectivity | 15 |
meeting | 15 |
consequently | 15 |
nucleotide | 15 |
inhibited | 15 |
awareness | 15 |
takes | 15 |
hypotheses | 15 |
integrated | 15 |
sustained | 15 |
adjusting | 15 |
routes | 15 |
scenario | 15 |
del | 15 |
rats | 15 |
defining | 15 |
suffered | 15 |
sclerosis | 15 |
canada | 15 |
serine | 15 |
absolute | 15 |
danish | 15 |
pbs | 15 |
simple | 15 |
alpha | 15 |
younger | 15 |
institutional | 15 |
compare | 15 |
january | 15 |
complication | 15 |
ritonavir | 15 |
meningococcal | 15 |
prognosis | 15 |
lived | 15 |
promotes | 15 |
cutaneous | 15 |
ebola | 15 |
scores | 15 |
confirmation | 15 |
stronger | 15 |
vulnerable | 15 |
note | 15 |
residual | 15 |
titers | 15 |
created | 15 |
researchers | 15 |
identical | 15 |
urologic | 15 |
oxide | 15 |
nearly | 15 |
epitope | 15 |
perspective | 15 |
update | 15 |
immunogenic | 15 |
hsp | 15 |
indonesia | 15 |
soluble | 15 |
networks | 14 |
lavage | 14 |
final | 14 |
attention | 14 |
utilized | 14 |
subclass | 14 |
circulation | 14 |
till | 14 |
pilot | 14 |
objective | 14 |
continue | 14 |
cytosol | 14 |
microbiology | 14 |
tend | 14 |
acids | 14 |
stability | 14 |
consanguinity | 14 |
analysed | 14 |
classified | 14 |
grant | 14 |
di | 14 |
characteristic | 14 |
materials | 14 |
collaboration | 14 |
york | 14 |
feasibility | 14 |
quantitative | 14 |
ankara | 14 |
predominantly | 14 |
antibacterial | 14 |
conserved | 14 |
pathogenicity | 14 |
enough | 14 |
pnp | 14 |
jurisdictions | 14 |
adhesion | 14 |
gdp | 14 |
pa | 14 |
killing | 14 |
balanced | 14 |
freedom | 14 |
monoclonal | 14 |
kir | 14 |
actual | 14 |
undergoing | 14 |
black | 14 |
negligible | 14 |
largely | 14 |
discontinued | 14 |
home | 14 |
uptake | 14 |
inhibitory | 14 |
nbs | 14 |
angiotensin | 14 |
nan | 14 |
subset | 14 |
barrier | 14 |
widespread | 14 |
aspects | 14 |
immunizations | 14 |
occurring | 14 |
japanese | 14 |
reuse | 14 |
formulations | 14 |
undergo | 14 |
positivity | 14 |
bands | 14 |
iris | 14 |
malignant | 14 |
identifier | 14 |
bank | 14 |
fight | 14 |
tlrs | 14 |
unclear | 14 |
norway | 14 |
adem | 14 |
influences | 14 |
seroconversion | 14 |
icu | 14 |
accepted | 14 |
persons | 14 |
treating | 14 |
prague | 14 |
acnes | 14 |
elicitation | 14 |
attacks | 14 |
rpm | 14 |
blocking | 14 |
hubs | 14 |
workflow | 14 |
polymerase | 14 |
describe | 14 |
extracellular | 14 |
ago | 14 |
stimulating | 14 |
males | 14 |
ards | 14 |
basic | 14 |
men | 14 |
suffer | 14 |
named | 14 |
transient | 14 |
receive | 14 |
descriptive | 14 |
travel | 14 |
improving | 14 |
eliminate | 14 |
connection | 14 |
driven | 14 |
dates | 14 |
relevance | 14 |
endogenous | 14 |
carrier | 13 |
traditional | 13 |
regulators | 13 |
modelling | 13 |
viability | 13 |
dapsone | 13 |
instillation | 13 |
migration | 13 |
intention | 13 |
strength | 13 |
dramatic | 13 |
glycosylation | 13 |
lessons | 13 |
confers | 13 |
urology | 13 |
progenitor | 13 |
changing | 13 |
shortage | 13 |
masses | 13 |
primates | 13 |
primed | 13 |
depending | 13 |
ivs | 13 |
tuberculous | 13 |
transformed | 13 |
opportunistic | 13 |
build | 13 |
surfaces | 13 |
shedding | 13 |
equal | 13 |
dermatitis | 13 |
infusions | 13 |
utility | 13 |
immunosuppressed | 13 |
evaluating | 13 |
normalized | 13 |
fumarate | 13 |
society | 13 |
odds | 13 |
fetal | 13 |
hosts | 13 |
outpatient | 13 |
polysaccharide | 13 |
specificity | 13 |
retrospectively | 13 |
labvs | 13 |
engineered | 13 |
phenomenon | 13 |
narcolepsy | 13 |
particles | 13 |
throat | 13 |
equation | 13 |
define | 13 |
duplication | 13 |
differentially | 13 |
nw | 13 |
investigations | 13 |
symptom | 13 |
crisis | 13 |
sle | 13 |
bound | 13 |
nephrectomy | 13 |
interact | 13 |
rb | 13 |
regulates | 13 |
preparation | 13 |
remarkable | 13 |
percent | 13 |
atherosclerotic | 13 |
viremia | 13 |
intraperitoneal | 13 |
understand | 13 |
naive | 13 |
heterozygous | 13 |
registered | 13 |
feeding | 13 |
accompanied | 13 |
sputum | 13 |
ctl | 13 |
discussion | 13 |
fda | 13 |
missing | 13 |
modulating | 13 |
coefficients | 13 |
mexico | 13 |
address | 13 |
concerning | 13 |
methodology | 13 |
eg | 13 |
emerged | 13 |
advances | 13 |
drop | 13 |
mannose | 13 |
omenn | 13 |
centers | 13 |
loaded | 13 |
purified | 13 |
looking | 13 |
genomics | 13 |
shared | 13 |
cmc | 13 |
apoptosis | 13 |
pbmo | 13 |
mitigate | 13 |
regulator | 13 |
neurological | 13 |
turn | 13 |
fatigue | 13 |
platelet | 13 |
evident | 13 |
unpublished | 13 |
modeling | 13 |
makes | 13 |
pathologic | 13 |
oxidase | 13 |
mathematical | 13 |
urban | 13 |
idea | 13 |
comprehensive | 13 |
minimum | 13 |
manner | 13 |
length | 13 |
correlates | 13 |
mortalities | 13 |
ty | 13 |
physicians | 13 |
rash | 13 |
pharmaceutical | 12 |
taking | 12 |
mir | 12 |
oxldl | 12 |
adt | 12 |
heterogeneity | 12 |
histological | 12 |
insignificant | 12 |
mitigation | 12 |
tumour | 12 |
phagocytes | 12 |
implants | 12 |
substrains | 12 |
dengue | 12 |
girls | 12 |
immunoprophylaxis | 12 |
province | 12 |
considerations | 12 |
shortages | 12 |
predominant | 12 |
george | 12 |
correlate | 12 |
opportunity | 12 |
purpura | 12 |
reasonable | 12 |
pediatricians | 12 |
baby | 12 |
connections | 12 |
maintain | 12 |
glutamine | 12 |
corynebacterium | 12 |
tm | 12 |
psa | 12 |
augmented | 12 |
plant | 12 |
proliferative | 12 |
fibrosis | 12 |
alleles | 12 |
bars | 12 |
pandemics | 12 |
rct | 12 |
extension | 12 |
suffering | 12 |
parasitic | 12 |
homeostasis | 12 |
demand | 12 |
chemical | 12 |
label | 12 |
demonstrating | 12 |
structures | 12 |
workshop | 12 |
experiences | 12 |
orf | 12 |
eosinophilic | 12 |
eventually | 12 |
hsa | 12 |
untreated | 12 |
lymphoid | 12 |
ko | 12 |
insertion | 12 |
atypical | 12 |
explore | 12 |
exhibited | 12 |
integrity | 12 |
pseudomonas | 12 |
chromosome | 12 |
interesting | 12 |
safely | 12 |
uses | 12 |
designs | 12 |
accounting | 12 |
growing | 12 |
quite | 12 |
avium | 12 |
tocilizumab | 12 |
elements | 12 |
decreases | 12 |
transplanted | 12 |
sensitive | 12 |
suppressed | 12 |
respond | 12 |
comparisons | 12 |
influenced | 12 |
foxp | 12 |
licensed | 12 |
malaysia | 12 |
polio | 12 |
eosinophils | 12 |
ca | 12 |
aps | 12 |
medicines | 12 |
indirect | 12 |
media | 12 |
paediatric | 12 |
penile | 12 |
ten | 12 |
diagnoses | 12 |
http | 12 |
transmembrane | 12 |
neither | 12 |
pathological | 12 |
techniques | 12 |
concomitant | 12 |
esat | 12 |
insights | 12 |
look | 12 |
anemia | 12 |
scientists | 12 |
perspectives | 12 |
ethical | 12 |
dying | 12 |
metabolites | 12 |
staphylococcus | 12 |
organs | 12 |
distributed | 12 |
employed | 12 |
decline | 12 |
august | 12 |
prominent | 12 |
bcgitis | 12 |
iqr | 12 |
narrative | 12 |
methylation | 12 |
scientificreports | 12 |
synthesized | 12 |
suggestive | 12 |
proof | 12 |
locally | 12 |
med | 12 |
endothelial | 12 |
predicts | 12 |
entire | 12 |
allowing | 12 |
lactococcus | 12 |
government | 12 |
telangiectasia | 12 |
rank | 12 |
logarithm | 12 |
tools | 12 |
glaxo | 12 |
specialized | 11 |
formula | 11 |
switch | 11 |
inducible | 11 |
event | 11 |
examine | 11 |
diphtheria | 11 |
owing | 11 |
ethnic | 11 |
sigad | 11 |
shorter | 11 |
clade | 11 |
papillomavirus | 11 |
airway | 11 |
collection | 11 |
intensity | 11 |
attempt | 11 |
standards | 11 |
unexpected | 11 |
largest | 11 |
lg | 11 |
took | 11 |
critically | 11 |
arm | 11 |
mevalonate | 11 |
antigenic | 11 |
power | 11 |
contrary | 11 |
synthase | 11 |
purpose | 11 |
accurate | 11 |